CFO and Executive Vice President, Bristol-Myers Squibb
There is increasing importance of differentiation in the pharmaceutical industry, especially given the political, regulatory,
and financial challenges we face. That's why BMS is executing a clear strategy to become a leading biopharma company while
remaining focused on operational excellence and strengthening our balance sheet. What is needed now more than ever is the
ability to turn challenges into opportunities; we're working to make sure BMS is well positioned to do so.
An innovative environment naturally creates leadership, and provides opportunities for successful, driven people. I make sure
that the people whom I work with have what they need in order to be successful. We're all doers here, and that spirit will
help us transform into the biopharma company we know we can be.